» Articles » PMID: 34040369

Biogenesis, Membrane Trafficking, Functions, and Next Generation Nanotherapeutics Medicine of Extracellular Vesicles

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2021 May 27
PMID 34040369
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular vesicles (EVs) are a heterogeneous group of membrane-limited vesicles and multi-signal messengers loaded with biomolecules. Exosomes and ectosomes are two different types of EVs generated by all cell types. Their formation depends on local microdomains assembled in endocytic membranes for exosomes and in the plasma membrane for ectosomes. Further, EV release is a fundamental process required for intercellular communication in both normal physiology and pathological conditions to transmit/exchange bioactive molecules to recipient cells and the extracellular environment. The unique structure and composition of EVs enable them to serve as natural nanocarriers, and their physicochemical properties and biological functions can be used to develop next-generation nano and precision medicine. Knowledge of the cellular processes that govern EVs biology and membrane trafficking is essential for their clinical applications. However, in this rapidly expanding field, much remains unknown regarding EV origin, biogenesis, cargo sorting, and secretion, as well as EV-based theranostic platform generation. Hence, we present a comprehensive overview of the recent advances in biogenesis, membrane trafficking, and functions of EVs, highlighting the impact of nanoparticles and oxidative stress on EVs biogenesis and release and finally emphasizing the role of EVs as nanotherapeutic agents.

Citing Articles

Extracellular vesicle-mediated bidirectional communication between the liver and other organs: mechanistic exploration and prospects for clinical applications.

Mo W, Peng Y, Zheng Y, Zhao S, Deng L, Fan X J Nanobiotechnology. 2025; 23(1):190.

PMID: 40055724 PMC: 11889855. DOI: 10.1186/s12951-025-03259-4.


Leveraging RNA interference technology for selective and sustainable crop protection.

Qi H, Zhang D, Liu B, Chen J, Han D, Wang D Front Plant Sci. 2025; 15():1502015.

PMID: 39777080 PMC: 11703868. DOI: 10.3389/fpls.2024.1502015.


Impact of H37Rv Infection on Extracellular Vesicle Cargo in Macrophages: Implications for Host-Pathogen Interaction.

Salgado-Cantu M, Gutierrez-Gonzalez L, Guzman-Beltran S, Herrera M, Sarabia C, Gonzalez Y Microorganisms. 2025; 12(12.

PMID: 39770608 PMC: 11678565. DOI: 10.3390/microorganisms12122405.


Emerging role of exosomes during the pathogenesis of viral hepatitis, non-alcoholic steatohepatitis and alcoholic hepatitis.

Shi C, Hu S, Liu S, Jia X, Feng Y Hum Cell. 2024; 38(1):26.

PMID: 39630211 DOI: 10.1007/s13577-024-01158-8.


The role of exosomes in liver cancer: comprehensive insights from biological function to therapeutic applications.

Zhang Y, Zhang C, Wu N, Feng Y, Wang J, Ma L Front Immunol. 2024; 15:1473030.

PMID: 39497820 PMC: 11532175. DOI: 10.3389/fimmu.2024.1473030.


References
1.
Sudnitsyna J, Skverchinskaya E, Dobrylko I, Nikitina E, Gambaryan S, Mindukshev I . Microvesicle Formation Induced by Oxidative Stress in Human Erythrocytes. Antioxidants (Basel). 2020; 9(10). PMC: 7650597. DOI: 10.3390/antiox9100929. View

2.
Dores M, Chen B, Lin H, Soh U, Paing M, Montagne W . ALIX binds a YPX(3)L motif of the GPCR PAR1 and mediates ubiquitin-independent ESCRT-III/MVB sorting. J Cell Biol. 2012; 197(3):407-19. PMC: 3341166. DOI: 10.1083/jcb.201110031. View

3.
Montecalvo A, Larregina A, Shufesky W, Stolz D, Sullivan M, Karlsson J . Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood. 2011; 119(3):756-66. PMC: 3265200. DOI: 10.1182/blood-2011-02-338004. View

4.
Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View

5.
Rosell A, Havervall S, von Meijenfeldt F, Hisada Y, Aguilera K, Grover S . Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report. Arterioscler Thromb Vasc Biol. 2020; 41(2):878-882. PMC: 7837685. DOI: 10.1161/ATVBAHA.120.315547. View